22NW, LP — 13F Holdings & Portfolio
CIK 1694297 · latest 13F-HR filed 2026-05-15
22NW, LP manages $145.9M in 13F-reported U.S. long-equity assets across 16 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are FSTR (20.41%), NKTR (13.86%), LFCR (12.93%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 1 new position, exited 5, added to 6, and trimmed 8.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$145.9M
Long-equity book
16
Distinct positions
2026-03-31
Filed 2026-05-15
+1 / −5 / ↑6 / ↓8
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- INSPERITY INC$9.6M +257.5%
- NEKTAR THERAPEUTICS$6.2M +44.5%
- ELEDON PHARMACEUTICALS INC$999.1K +104.0%
- REZOLUTE INC$566.3K +29.2%
- CORE MOLDING TECHNOLOGIES IN$523.4K +11.7%
Top Trims
- REGENXBIO INC-$9.2M -69.0%
- LIFECORE BIOMEDICAL INC-$4.2M -18.1%
- PHENIXFIN CORP-$3.5M -67.7%
- FOSTER L B CO-$2.3M -7.2%
- CULP INC-$1.5M -23.0%
Exited Positions
- ANEBULO PHARMACEUTICALS INC$84.8M
- MAYVILLE ENGR CO INC$7.8M
- MEIRAGTX HLDGS PLC$4.7M
- STRATA SKIN SCIENCES INC$676.6K
- PSYCHEMEDICS CORPORATION CMN$441.7K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | FOSTER L B CO | FSTR | 350060109 | $29.8M | 20.41% | 1,067,186 | SH |
| 2 | NEKTAR THERAPEUTICS | NKTR | 640268306 | $20.2M | 13.86% | 281,115 | SH |
| 3 | LIFECORE BIOMEDICAL INC | LFCR | 514766104 | $18.9M | 12.93% | 1,254 | SH |
| 4 | INSPERITY INC | NSP | 45778Q107 | $13.3M | 9.14% | 493,000 | SH |
| 5 | MINERALYS THERAPEUTICS INC | MLYS | 603170101 | $12.0M | 8.25% | 444,325 | SH |
| 6 | STONERIDGE INC | SRI | 86183P102 | $11.9M | 8.17% | 2,466,975 | SH |
| 7 | FOX FACTORY HLDG CORP | FOXF | 35138V102 | $11.2M | 7.65% | 678,165 | SH |
| 8 | CULP INC | CULP | 230215105 | $5.1M | 3.49% | 1,859,061 | SH |
| 9 | CORE MOLDING TECHNOLOGIES IN | CMT | 218683100 | $5.0M | 3.42% | 222,738 | SH |
| 10 | REGENXBIO INC | RGNX | 75901B107 | $4.1M | 2.83% | 492,759 | SH |
| 11 | UNIFI INC | UFI | 904677200 | $3.0M | 2.09% | 852,455 | SH |
| 12 | TEAM INC | TISI | 878155308 | $2.7M | 1.86% | 170,187 | SH |
| 13 | REZOLUTE INC | RZLT | 76200L309 | $2.5M | 1.72% | 820,653 | SH |
| 14 | FARMER BROS CO | FARM | 307675108 | $2.5M | 1.70% | 1,955,526 | SH |
| 15 | ELEDON PHARMACEUTICALS INC | ELDN | 28617K101 | $2.0M | 1.34% | 636,364 | SH |
| 16 | PHENIXFIN CORP | PFX | 71742W103 | $1.7M | 1.15% | 43,115 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $145.9M | 16 | 0001214659-26-006481 |
| 2025-12-31 | 2026-02-13 | $237.6M | 20 | 0001214659-26-001725 |
| 2025-09-30 | 2025-11-14 | $212.3M | 21 | 0001214659-25-016649 |